Replacing standard laboratory tests for chlamydia and gonorrhoea with a rapid point of care test could be cost-effective if implemented in genitourinary medicine clinics in England. It could save the National Health Service an estimated £10 million annually, and patients would benefit from fewer unnecessary treatments and reduced complications from infection, and it could prevent the number of transmissions.
Turner KME, Round J, Horner PJ, et. al. What are the clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary medicine clinics in England? Sex Transm Infect. Published online 22 Nov 2013: doi:10.1136/sextrans-2013-051147